Overview
Selank is a synthetic peptide analogue of tuftsin, an endogenous immunomodulatory tetrapeptide. Extending the tuftsin sequence improves its metabolic stability, and Selank has become a widely referenced research compound for exploring anxiolytic pathways without the sedative or dependence liabilities associated with conventional benzodiazepine-class research comparators.
Nova Biolabs supplies Selank 10mg in lyophilised form from UK domestic stock.
Key Research Areas
Anxiolytic Pathway Research
Selank is studied for its anxiolytic-like effects in animal models, investigated as a research alternative that avoids sedation and motor-impairment endpoints.
GABA & Serotonin Modulation
Investigated for its modulatory effects on GABAergic and serotonergic signalling systems relevant to mood and stress-response research.
Neuroimmune Signalling
As a tuftsin analogue, Selank is studied for immunomodulatory activity and crosstalk between neural and immune signalling pathways.
BDNF Expression Research
Explored alongside related neuropeptides for its potential influence on brain-derived neurotrophic factor (BDNF) expression models.
Product Specifications
| Format | Lyophilised powder |
| Quantity | 10mg per vial |
| Grade | Research Grade |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Origin | UK domestic stock |
| Research use | In vitro / laboratory use only |
Frequently Asked Questions
Commonly Stacked With
Compounds researchers often study alongside this one, and why.
Often studied alongside Semax for comparative research — calming vs. stimulating nootropic signalling profiles from the same research programme.
Calming-signalling and cellular-energy research are sometimes combined for broader neurological-support study protocols.
Occasionally paired for broader neuroprotective and antioxidant research coverage.